|
WO2021001485A1
|
|
Hygiene detection device and use thereof for monitoring hygiene compliance
|
|
US2016008376A1
|
|
Compositions, Methods and Uses for Treating Gender-Biased Immune Disorders
|
|
US2015216869A1
|
|
Drug Combinations and Uses in Treating a Coughing Condition
|
|
US2015005325A1
|
|
Drug Combinations and Uses in Treating a Coughing Condition
|
|
CN105142631A
|
|
Cancer drug and uses
|
|
EP2911659A2
|
|
Drug combinations and uses
|
|
EP2670389A1
|
|
Compositions and methods for treating cardiovascular diseases
|
|
GB201113730D0
|
|
Solid dosage form
|
|
GB201113729D0
|
|
Hyperlipidaemia
|
|
GB201111485D0
|
|
Drug composition and its use in therapy
|
|
GB201101937D0
|
|
Method of preparing a composition
|
|
GB201021425D0
|
|
Drug composition and its use in therapy
|
|
GB201019972D0
|
|
Drug composition and its use in therapy
|
|
GB201019971D0
|
|
Drug composition and its use in therapy
|
|
GB201018302D0
|
|
Treatment of a Th-1 mediated disease
|
|
GB201018289D0
|
|
Treatment of respiratory disorders
|
|
GB201015878D0
|
|
A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
|
|
GB201014391D0
|
|
Drug composition and its use in therapy
|
|
AU2010283583A1
|
|
Treatment of viral infections
|
|
GB201012168D0
|
|
A compound for use in treating an acute viral infection
|
